Safety and complications of central venous catheters in AIDS patients E.C.J. Consten, J.J.B. van Lanschot, F.M. Movig, L. Rijsman, J. Oosting, S.A. Danner  Clinical Microbiology and Infection  Volume 4, Issue 9, Pages 508-513 (September 1998) DOI: 10.1111/j.1469-0691.1998.tb00405.x Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Cumulative incidence of complications per month for the three different groups. Group A (interrupted line) consisted of AIDS patients; group B (thick line) consisted of immunocompromised patients with a diagnosis of solid tumor, lymphoma, or acute or chronic leukemia, and treated with chemotherapeutic agents; group C (thin line) consisted of patients with negligible immunosuppression with a diagnosis of short bowel syndrome, pseudo-obstruction syndrome or Crohn's disease. Clinical Microbiology and Infection 1998 4, 508-513DOI: (10.1111/j.1469-0691.1998.tb00405.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions